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Iron induces two distinct Ca2+ signalling cascades
in astrocytes
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Iron is the fundamental element for numerous physiological functions. Plasmalemmal divalent
metal ion transporter 1 (DMT1) is responsible for cellular uptake of ferrous (Fe2+), whereas
transferrin receptors (TFR) carry transferrin (TF)-bound ferric (Fe3+). In this study we per-
formed detailed analysis of the action of Fe ions on cytoplasmic free calcium ion con-
centration ([Ca2+]i) in astrocytes. Administration of Fe2+ or Fe3+ in μM concentrations
evoked [Ca2+]i in astrocytes in vitro and in vivo. Iron ions trigger increase in [Ca2+]i through
two distinct molecular cascades. Uptake of Fe2+ by DMT1 inhibits astroglial Na+-K+-ATPase,
which leads to elevation in cytoplasmic Na+ concentration, thus reversing Na+/Ca2+
exchanger and thereby generating Ca2+ influx. Uptake of Fe3+ by TF-TFR stimulates phos-
pholipase C to produce inositol 1,4,5-trisphosphate (InsP3), thus triggering InsP3 receptor-
mediated Ca2+ release from endoplasmic reticulum. In summary, these findings reveal the
mechanisms of iron-induced astrocytic signalling operational in conditions of iron overload.
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Iron contributes to numerous cellular and biochemical pro-cesses and acts as a co-factor in various molecular cascades inthe nervous tissue including the synthesis and metabolism of
several brain-specific enzymes and neurotransmitters1,2. In bio-
logical systems iron is present in either reduced ferrous (Fe2+) or
oxidized ferric (Fe3+) state. The brain has the second (after liver)
highest quantity of iron in the human body with total non-haem
iron in the brain reaching about 60 mg3. The non-haem iron
concentration in the serum ranges between 9 and 30 μM, whereas
the iron concentration in cerebrospinal fluid (CSF) is much
smaller being around 0.3–0.75 μM4,5. Transport of iron across the
blood–brain barrier (BBB) is mediated either by transferrin
receptor (TFR)-mediated endocytosis of Fe3+-bound to trans-
ferrin (holo-TF), or, for non-TF-bound iron, by vesicular and
non-vesicular pathways6. Membrane transport of Fe2+ is also
mediated by divalent metal ion transporter 1 (DMT1/SLC11A2)
which underlies Fe2+ uptake through the plasma membrane or
from endosomes6. Under physiological conditions, the intracel-
lular cytosolic ionised iron levels fluctuate around 0.5–1.5 μM7.
In the brain, up to three-fourths of total iron is accumulated
within neuroglial cells8. Astrocytes in particular are fundamental
elements of ionostatic control over CNS environment9. Ionised
Fe2+ enters astrocytes through DMT1/SLC11A2 transporters
which are particularly concentrated in the endfeet of cerebral and
hippocampal astrocytes10. In physiological condition, DMT1 is
widely distributed in the nervous system, being expressed in
neurones11–13, astrocytes13–15 and oligodendrocytes14,16 in vitro
and in the brain tissue. In astrocytes, DMT1 mediates non‐
transferrin‐bound iron (NTBI) transport, thus contributing to the
brain iron homoeostasis in development and adulthood17–19.
Conditional deletion of DMT1 form oligodendrocyte precursors
substantially inhibited both myelination in development and
remyelination in pathology16. Evidence for the expression of TFR
in astroglial cells remains controversial6,20,21, while iron overload
may influence the expression or distribution of TFR in astrocytic
compartments21,22. Cellular uptake of Fe3+ requires internaliza-
tion of TF–TFR complex23. An adaptor protein Disabled-2
(Dab2) plays an essential role in cell signalling, migration and
development24. In mice the Dab2 has two isoforms of 96 and 67
kDa (p96 and p6724). In human K562 cells, Dab2 regulates
internalization of TFR and uptake of TF25. Dab2 is also widely
distributed in immune cells and in neuroglia24, although the
functional link between Dab-2 and TFR in astrocytes has not
been demonstrated.
Astrocytes possess a special form of intracellular ionic excit-
ability, mediated by temporal and spatial fluctuations in the
intracellular ion concentration26,27. Astroglial Ca2+ signalling is
mediated by Ca2+ release from the endoplasmic reticulum (ER)
following activation of inositol-1,4,5-trisphosphate receptor
(InsP3R), or intracellular Ca2+-gated Ca2+ channels known as
ryanodine receptors (RyR). Astroglial Ca2+ signals may also be
generated by plasmalemmal Ca2+ entry through Ca2+-permeable
channels or by sodium-calcium exchanger (NCX) operating in the
reverse mode26,28. Astroglial Na+ signalling is shaped by plas-
malemmal Na+ entry through cationic channels and numerous
Na+-dependent transporters, of which the major role belongs to
Na+-dependent glutamate transporters29–31; Na+ extrusion is
mediated by the sodium-potassium pump (NKA). Both Na+ and
Ca2+ signalling systems are closely coordinated, with NKA and
NCX accomplishing this coordination at the molecular level32.
Astrocytes specifically express α2-subunit containing NKA which
is fundamental for astroglial K+ buffering33. Astrocytes express all
three isoforms of NCX - NCX1/SLC8A1, NCX2/SLC8A2 and
NCX3/SLC8A3, with some evidence indicating higher expression
of NCX134. The NKA, the NCX and glutamate transporters are
known to be preferentially concentrated in the perisynaptic
astroglial membranes indicating intimate relationship between
these ion-transporting molecules35,36. The NCX is also known to
localise at caveolae rich in caveolin-3 (Cav-3), the latter isoform
being predominantly expressed in astrocytes37.
In the present paper we performed an in depth analysis of the
action of ferrous and ferric (Fe2+ and Fe3+) on astrocytic Ca2+
and Na+ dynamics. We found that Fe2+ (through DMT1) and
Fe3+-TF (through TFR) evoke [Ca2+]i transients in astrocytes in
culture and in vivo. Effects of Fe2+ on [Ca2+]i are mediated
mainly by the reversed NCX, whereas Fe3+ triggers Ca2+ release
from the endoplasmic reticulum by stimulations of InsP3R. In
conclusion, we discovered that iron ions trigger astrocytic Ca2+
signalling by acting through two distinct molecular cascades.
Results
Fe2+/Fe3+ trigger [Ca2+]i increase in cortical astrocytes
in vitro and in vivo. Exposure of cultured astrocytes to Fe2+
leads to a gradual increase in cytoplasmic Fe2+ concentration as
revealed by quenching of Fura-2 (Supplementary Figure 1).
Washout of Fe2+ leads to a full recovery of Fura-2 fluorescence;
these data indicate the existence of plasmalemmal Fe2+ transport
system as well as absence of non-specific damaging effect of
ionised iron on the cellular membrane. We analysed effects of
Fe2+ and Fe3+ Ca2+ dynamics in astrocytes in primary cultures
and in vivo in GFAP-eGFP transgenic mice (Fig. 1). In the pri-
mary cultured astrocytes, administration of either FeSO4 (Fe2+)
or ferric ammonium citrate-TF (Fe3+) increased [Ca2+]i in
concentration-dependent manner, albeit with different kinetics.
In the presence of Fe2+ an increase in [Ca2+]i demonstrated
prominent plateau, whereas Fe3+ triggered transient, relatively
rapidly decaying [Ca2+]i response (Fig. 1a).
When imaging cortical astrocytes in vivo (the cells were
identified by specific eGFP fluorescence) we found that addition
of either Fe2+ or Fe3+ for 30 s induced transient [Ca2+]i increase
(Fig. 1b). Administration of Fe2+ increased fluorescent intensity
of Rhod-2 to 456.30% ± 18.46% (n= 10, p < 0.0001) whereas Fe3+
increased the peak of fluorescent signal to 308.50% ± 13.01%
(n= 10, p < 0.0001) of the basal value. In experiments in vitro we
characterised concentration-dependence of [Ca2+]i responses: the
EC50 was around 0.4–0.6 μM for both Fe2+ and Fe3+ (Fig. 1c).
DMT1 and TFR mediate Fe2+ and Fe3+ uptake. As mentioned
above, Fe2+ uptake could be mediated by plasmalemmal trans-
porter DMT1, whereas Fe3+ is mainly accumulated in TF-bound
form by TFRs (Fig. 2a). Immunostaining of cortical tissue pre-
parations and primary cultured astrocytes demonstrated co-
localisation of DMT1 and TFR with astroglial GFAP-positive
profiles (Fig. 2b). In the cortical tissue both DMT1 and TFR are
preferentially localised at perivascular endfeet. Meanwhile,
expression of specific DMT1 and TFR mRNA was also detected
in the freshly isolated and sorted astrocytes and neurones, as well
as and in the cerebral tissue (Fig. 2c).
To reveal the contribution of DMT1 and TFR to Fe2+/
Fe3+-induced [Ca2+]i dynamics, we inhibited expression of
DMT1 or TFR using siRNA duplex chains. The representative
western blots demonstrating the efficacy of knockdown are shown
in Fig. 2d. When compared to the control group, the
DMT1 siRNA reduced expression of DMT1 to 9.52% ± 2.58%
(n= 6, p < 0.0001), whereas treatment with TFR siRNA decreased
TFR levels to 7.84% ± 2.10% (n= 6, p < 0.0001) from the control
values. Administration of Fe2+ to DMT1-deficient astrocytes
failed to induce any changes in [Ca2+]i. At the same time Fe2+
induced robust [Ca2+]i elevation in astrocytes treated with
siRNA(−) (Fig. 2e). Similarly, Fe3+ did not produce [Ca2+]i,
transients in astrocytes treated with TFR siRNA duplex chains,
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whereas in cells exposed to negative control siRNA Fe3+ evoked
[Ca2+]i elevations (Fig. 2e). At the same time Fe3+-induced
[Ca2+]i transients were fully preserved in DMT1-deficient
astrocytes (Supplementary Figure 2), hence questioning the role
of DMT1 in release of Fe3+ from endosomes.
In unstimulated astrocytes in culture the DMT1 fluorescence
was the highest around the nucleus, suggesting its preferred
intracellular localisation. After treatment of cultures with Fe2+ for
5 min we observed redistribution of DMT1 from the nuclear
region to the plasma membrane (Fig. 2f). The levels of DMT1
were measured in the extracted proteins of the nucleus and
cytoplasm (Fig. 2g). After treatment with Fe2+ for 5 min, the level
of DMT1 in the nuclei decreased to 36.41% ± 4.33% of control
group (n= 10, p < 0.0001), whereas the level of cytoplasmic
DMT1 increased to 117.37% ± 5.79% of control group (n= 10,
p < 0.0001) (Fig. 2g).
Sources of iron-induced [Ca2+]i mobilisation. The main sources
for [Ca2+]i increase in astrocytes are (i) Ca2+ release from the ER
following the opening of InsP3Rs or RyRs, or (ii) plasmalemmal
Ca2+ influx through either Ca2+ permeable channels (such as
L-type Ca2+ channels or TRP channels) or NCX operating in the
reverse mode (Fig. 3a) or (iii) combination of some or all of these
pathways. To dissect Ca2+ sources we first determined the
influence of extracellular Ca2+ on iron-evoked [Ca2+]i transients.
Removal of Ca2+ from the extracellular milieu completely abol-
ished Fe2+-induced [Ca2+]i elevations but left Fe3+-evoked
[Ca2+]i transients largely intact (Fig. 3b). This highlights the role
for plasmalemmal Ca2+ influx in Ca2+ signalling triggered by
Fe2+ and ER Ca2+ release for Ca2+ signals triggered by Fe3+.
Incubation of astrocytes with inhibitor of L-type voltage-gated
Ca2+ channel nifedipine (10 μM) did not affect [Ca2+]i responses
to Fe2+ or to Fe3+ (Fig. 3c). In contrast, inhibition of NCX with
Fig. 1 Iron ions, Fe2+ and Fe3+, evoke astrocytic intracellular Ca2+ signals in vitro and in vivo. a Representative images (top panel) and intracellular
Ca2+ ([Ca2+]i) recordings from primary cultured astrocytes in response to different concentrations of Fe2+ or Fe3+. Every data point represents mean ±
SD, n= 10, p < 0.05, statistically significant difference from the value of baseline in the same group. The experiment was repeated in 10 different cultures.
The representative image on the left shows the primary cultured astrocytes co-stained with GLT1 (green), GFAP (red), and DAPI (blue). Representative
Fluo-4 images (green) show astrocytes treated by 10 μM Fe2+ or Fe3+ at 0 s and 105 s of the recordings, the astrocytic identity was confirmed by co-
staining with SR101. Scale bar, 20 μm. b Images (top panel) and [Ca2+]i recordings from cortical astrocytes in GFAP-eGFP transgenic mice using
transcranial confocal microscopy. Every data point represents mean ± SD, n= 10 (different mice), p < 0.05, statistically significant difference from the value
of baseline in the same group. Representative Rhod-2 images (red) show astrocytes treated with 100 μM Fe2+ or Fe3+ at 0 s (baseline) and 45 s (peak of
the response); GFAP-eGFP images (green) are shown on the right. Scale bar, 10 μm. c Concentration-dependence of the maximal amplitude of [Ca2+]i
responses triggered by Fe2+ or Fe3+ in cultured astrocytes.
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10 μM of selective agonist KB-R7943 completely eliminated
[Ca2+]i responses to Fe2+, without affecting Fe3+-induced
[Ca2+]i transients (Fig. 3d). Thus, two forms of iron, the ferrous
and the ferric, mobilise intracellular Ca2+ through distinct
pathways: Fe2+ stimulates Ca2+ influx by NCX, whereas Fe3+
triggers intracellular Ca2+ release. This suggestion was further
corroborated by pharmacological inhibition of InsP3 receptors
with potent antagonist Xestospongin C (XeC)38, Exposure of
cultured astrocytes to 10 μM of XeC effectively suppressed
[Ca2+]i response to Fe3+, without much affecting Fe2+-induced
[Ca2+]i transient (Fig. 3e). Finally, treatment with 10 μM
ryanodine (which at this concentration inhibits RyRs) somewhat
decreased the plateau phase of Fe2+-induced [Ca2+]i transient
without modifying [Ca2+]i response to Fe3+ (Fig. 3f).
DMT1 transports Fe2+, which inhibits NKA, increases [Na+]i
and reverses NCX. Experiments described above have demon-
strated that Fe2+, after being transported into the cell by DMT1,
leads to a reversal of the NCX, which results in Ca2+ influx. The
NCX reversal in astrocytes is triggered by an increase in [Na+]i.
Such an increase may originate either from the activation of
plasmalemmal Na+ entry or from inhibition of the NKA, which
maintains basal [Na+]i28,30. The activity of NKA was suppressed
by exposure to 10 μM Fe2+ to 82.40 ± 5.74% (n= 10, p < 0.0001)
of the control. Exposure to 100 nM of the specific NKA inhibitor,
ouabain, reduced NKA activity to 72.30 ± 5.91% (n= 10, p <
0.0001) of the control (Fig. 4a). When 10 μM Fe2+ and 100 nM
ouabain were added together, the NKA activity was reduced to
71.80 ± 7.81% (n= 10, p < 0.0001) (Fig. 4a).
Inhibition of NKA in astrocytes results in a substantial
elevation in [Na+]i. When monitoring [Na+]i in cultured
astrocytes with Na+-sensitive probe SBFI we found that both
Fe2+ (10 μM) and ouabain (100 nM) triggered rapid and
substantial elevation of [Na+]i (Fig. 4b). These changes in [Na+]i
were paralleled by [Ca2+]i dynamics. Exposure of astrocytes to
Fe2+, or ouabaine or mixture of Fe2+ and ouabain caused [Ca2+]i
elevation (Fig. 4c). When Fe2+ was applied in the presence of
ouabain it failed to change [Ca2+]i (Fig. 4d); at the same time
application of Fe3+ in the presence of ouabain still triggered
additional [Ca2+]i elevation (Fig. 4d).
Fe2+-induced Ca2+ mobilisation is associated with caveolae.
Treatment of cultured astrocytes with interfering Cav3 siRNA
duplex chains decreased the level of Cav3 to 7.41 ± 4.32% (n= 6,
p < 0.0001) of the control (Fig. 4e). An in vitro knock-down of
Cav3 significantly reduced amplitudes of Fe2+-induced [Ca2+]i
Fig. 2 Astrocytic expression of DMT1 and TFR. a Astrocytes accumulate Fe2+ through plasmalemmal divalent metal transporter 1 (DMT1/SLC11A2)
whereas Fe3+ is taken up by internalisation of Fe3+-TF-TFR complex. b Images of astrocytes in the somato-sensory cortex preparations or in primary
culture double-immunolabeled with antibodies against DMT1 or TFR and against GFAP. Scale bar, 20 μm. c The mRNA expression of DMT1 and TFR
measured by qPCR in astrocytes sorted from GFAP-GFP mice, in neurones sorted from Thy1-YFP mice, and in whole cerebral tissue of wild type mice.
d Representative western blot bands for DMT1 and TFR in cultured astrocytes treated with sham (Control), siRNA negative control (−) or positive duplex
chains (+). The protein levels are shown as the ratio of DMT1 (55 kDa) and β-actin (42 kDa), and TFR (92 kDa) and β-actin. Data represent mean ± SD,
n= 6. *Indicates statistically significant (p < 0.05) difference from the value of baseline in the same group. e [Ca2+]i transients evoked by Fe2+ or Fe3+
after RNA interference and down-regulation of protein synthesis. After treatment with DMT1 or TFR siRNA negative control (−) or positive duplex chains
(+) for 3 days, [Ca2+]i dynamics in response to Fe2+/Fe3+ was monitored. Every data point represents mean ± SD, n= 10. f Images of astrocytes in
primary culture treated with sham (Control) or Fe2+ for 5 min and double-immunolabelled with antibodies against DMT1 and against GFAP. Scale bar,
25 μm. g Redistribution of DMT1 induced by Fe2+ in the extracted proteins of nucleus and cytoplasm. Every data point represents mean ± SD, n= 10.
*Indicates statistically significant (p < 0.05) difference from control group.
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increase; maximal increase in Fluo-4 F/F0 after Cav3 knockdown
was 242.00 ± 16.44% (n= 10, p < 0.0001). In control astrocytes
treated with siRNA(−) the amplitude of Fe2+-induced [Ca2+]i
increase reached 363.34 ± 11.62% (n= 10, p < 0.0001, Fig. 4f). To
further analyse the effects of Cav3 on Fe2+-induced [Ca2+]i
dynamics the levels of relevant proteins were measured in the
extracted caveolae (Fig. 5a). As shown in Fig. 5B, exposure to
10 μM Fe2+ for 5 min significantly increased the level of DMT1
to 293.24 ± 24.89% (n= 10, p < 0.0001) of the control values.
After pre-treatment with Cav3 siRNA duplex chains, Fe2+
increased the level of DMT1 only to 195.77 ± 20.19% (n= 10, p <
0.0001) of control group (Fig. 5b). The levels of NCX1 and NKA
were similarly affected by Fe2+ and the knocking down of Cav3.
Exposure to Fe2+ increased the level of NCX1 and NKA to
248.71 ± 19.58% (n= 10, p < 0.0001) and 263.66 ± 25.93% (n=
10, p < 0.0001) of the controls, after knocking down Cav3, Fe2+
elevated the level of NCX1 and NKA only to 172.96 ± 11.76%
(n= 10, p < 0.0001) and 200.86 ± 18.14% (n= 10, p < 0.0001) of
Fig. 3 Ca2+ sources for Fe2+ or Fe3+-induced [Ca2+]i transients. a Possible pathways mediating Ca2+ influx into the cytosol. b [Ca2+]i recordings
performed in the Ca2+-free extracellular medium; removal of external Ca2+ abolished Fe2+ evoked [Ca2+]i increase; conversely [Ca2+]i transient evoked
by Fe3+ remains intact. c Pre-treatment with 10 μM nifedipine affects neither Fe2+ nor Fe3+-induced [Ca2+]i responses. d Pre-treatment with NCX
inhibitor KB-R7943 at 10 μM suppresses [Ca2+]i response to Fe2+ but not to Fe3+. e Pre-treatment with InsP3 receptor inhibitor XeC at 10 μM suppresses
[Ca2+]i response to Fe3+ but not to Fe2+. f Pre-treatment with 10 μM ryanodine (Ry), the inhibitor of ryanodine receptors, affects only plateau phase of
Fe2+-induced [Ca2+]i response. In b-f, every data point represents mean ± SD, n= 10.
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Fig. 4 Fe2+ reverses NCXs by inhibiting NKA. a NKA activity in the presence of Fe2+ and ouabain measured by ELISA; OD value was normalised to
controls. Data represent mean ± SD, n= 10. *Indicates statistically significant (p < 0.05) difference from control group; **indicates statistically significant
(p < 0.05) difference from any other group. b [Na+]i recordings from cultured astrocytes challenged with Fe2+ and ouabain as indicated on the graph (c)
and (d) [Ca2+]i recordings from cultured astrocytes challenged with Fe2+, Fe3+ and ouabain as indicated on the graph. For b, c and d every data point
represents mean ± SD, n= 10. e Representative western blot bands for Cav3 in cultured astrocytes treated with sham (Control), siRNA negative control
(−), or positive duplex chains (+) to down-regulate Cav3 expression. Protein values are shown as the ratio of Cav3 (22 kDa) to β-actin (42 kDa).
Data represent mean ± SD, n= 6. *Indicates statistically significant (p < 0.05) difference from any other group. f Cav3 RNA interference suppresses
Fe2+-induced [Ca2+]i response. Every data point represents mean ± SD, n= 10.
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control values (Fig. 5b). Of note, Fe2+ did not affect the levels of
NCX2 and NCX3 (Fig. 5b).
Fe3+ triggers Ca2+ release through stimulation of PLC and
increase in InsP3 production. As shown in Fig. 3e, inhibition of
InsP3 receptors with XeC suppressed Fe3+-induced [Ca2+]i
mobilisation. We therefore analysed effects of Fe3+ on the InsP3
signalling cascade in cultured astrocytes. Incubation of astrocytes
with Fe3+ increased the level of InsP3 in cell lysates to 74.10 ±
8.14 ng/ml (n= 10, p < 0.0001), from the control InsP3 level of
24.40 ± 6.35 ng/ml. In cells treated with TF alone the InsP3 level
was 28.00 ± 12.62 ng/ml (n= 10, p= 0.4309) (Fig. 6a). Subse-
quently we analysed the links between scaffolding/signalling
protein Dab2 and Fe3+-induced Ca2+ signalling. We suppressed
expression of two isoforms of Dab2 by siRNA duplex chains
(Fig. 6b). After RNA interfering, expression of 96 kD and 67 kD
Dab2 isoforms decreased, respectively, to 5.81 ± 3.56% (n= 6, p <
0.0001) and to 11.88 ± 6.51% (n= 6, p < 0.0001) of the control
values (Fig. 6b). The knock-down of Dab2 rendered Fe3+ inef-
fective: exposure of Dab2-deficient astrocytes to Fe3+ did not
affect InsP3 production (control: 31.60 ± 12.51 ng/ml (n= 10);
Dab2 knockdown: 30.60 ± 10.42 ng/ml (n= 10, p= 0.1253;
Fig. 6c).
When Dab2-deficient astrocytes were challenged with Fe3+, no
[Ca2+]i increase was recorded (Fig. 6d). Similarly, after inhibition
of the PLC with U-73122, application of Fe3+ did not change
[Ca2+]i (Fig. 6d). Hence, we may surmise that uptake of Fe3+
through TFR requires Dab2 protein; after entering the cytosol
Fe3+ activates the PLC, which produces InsP3 that triggers InsP3-
induced Ca2+ release from the ER (Fig. 6e).
Discussion
In this paper, we describe previously unknown effects of iron ions
on cellular [Ca2+]i in astrocytes. Administration of either Fe2+ or
Fe3+ triggered a concentration-dependent increase in [Ca2+]i
with EC50 of about 0.4–0.6 μM. We performed an in depth ana-
lysis of the mechanisms underlying iron transport and iron
induced Ca2+ signalling. We also demonstrated that, contrary to
the previous beliefs, astrocytes express functional TFR in vitro
and in vivo thus allowing accumulation of Fe3+.
In the brain, majority of cells express a full complement of
proteins responsible for iron homoeostasis, including TFR and
DMT1 for iron uptake, heavy and light chains ferritin for iron
Fig. 5 Caveolae integrate DMT1, NKA and NCX. a Representative protein western blot bands for DMT1, NCX1-3 and NKA-α1/α2 in caveolae membranes
extracted from cultured astrocytes. Astrocytes were treated with sham (Control), with siRNA negative control (−) or with Cav3 duplex chains (siRNA(+))
for 3 days. b Protein levels are shown as the ratio of DMT1 (55 kDa) and β-actin (42 kDa), NCX1 (108 kDa) and β-actin, NCX2 (102 kDa) and β-actin, NCX3
(100 kDa) and β-actin, NKA-α1/α2 (100 kDa) and β-actin (42 kDa). Data represent mean ± SD, n= 6. *Indicates statistically significant (p < 0.05)
difference from any other group; **indicates statistically significant (p < 0.05) difference from control plus Fe2+ group or Cav3 siRNA(+) plus Ctrl group.
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sequestration, cytosolic iron exporter ferroportin 1 (FPN1), and
iron regulatory protein 1 and 2 (IRP1and IRP2) for regulating
intracellular iron homoeostasis39,40. Glial cells, and astrocytes in
particular, store up to 75% of ionised iron in the CNS41, and
protect the brain against iron overloads42. Transmembrane
transport of iron in astrocytes has been identified, but was not
studied in details. There is a general agreement on the primary
role of plasmalemmal divalent metal transporter 1, DMT1/
SLC11A2, which selectively transports Fe2+; the DMT1 was
detected in astrocytes in culture and there is evidence indicating
its presence in astroglial endfeet in situ43–45. In addition, Fe2+
was suggested to enter reactive astrocytes by diffusion through
transient receptor potential canonical (TRPC) channels42.
Expression of TF-Fe3+-transporting TFR has been noted in
astrocytes in culture21,46; it is, nonetheless, generally believed that
astrocytes in vivo are not in a possession of TFR and hence
cannot accumulate Fe3+ 47–49. This conclusion, however, has
been made on the basis of rather limited investigations14,46; while
expression of TFR-specific mRNA was detected in astrocyte
transriptome50. In our study we confirmed expression of DMT1,
at mRNA and protein levels as well as by immunostaining, in
acutely isolated astrocytes, in astroglial primary culture and
in situ in cortical tissue; the DMT1 was particularly enriched in
the endfeet (Fig. 2b–d). We also detected astroglial expression of
TFR at mRNA level in the transcriptome of acutely isolated and
FACS-sorted astrocytes (Fig. 2c). We further confirmed expres-
sion of TFR in astrocytes at a protein level and in immunohis-
tochemical analysis of astrocytes in culture and in cortical
preparations (Fig. 2b–d). In the cortical tissue TFR labelling was
concentrated in perivascular astrocytic endfeet (Fig. 2b–d).
Not much is known about the links between ionised iron and
Ca2+ signalling in the cellular elements of the CNS. In the lit-
erature, we found only a single example of Fe3+-induced [Ca2+]i
transient in cultured hippocampal neurones51. To the best of our
knowledge here we present the first recordings of Fe2+/Fe3+
induced Ca2+ signals in astrocytes. Both ions evoked [Ca2+]i
elevation in primary cultured astrocytes and in EGFP-labelled
astrocytes in the cortices of alive animals studied with tran-
scranial confocal microscopy. Both ions acted in the low μM
range of concentrations, however the kinetics of respective
[Ca2+]i transients are different. Exposure of cultured astrocytes to
Fe2+ triggered rapid [Ca2+]i increase with long-lasting plateau;
the [Ca2+]i barely declined in the presence of Fe2+. In contrast,
Fe3+-induced transient elevation of [Ca2+]i recovers to the
baseline within ~ 200–300 s in the presence of Fe3+ (Figs. 1b
and 2e). These distinct kinetics reflect different signalling cas-
cades activated by iron ions.
The Fe2+-induced [Ca2+]i responses require DMT1: in vitro
knockdown of DMT1 expression with silencing mRNA com-
pletely eliminates Ca2+ signal (Fig. 2). The Fe2+-induced [Ca2+]i
Fig. 6 Mechanisms of Fe3+ induced Ca2+ signalling. a Incubation with Fe3+ increases InsP3 level in cultured astrocytes; InsP3 was measured with ELISA;
data are presented as mean ± SD, n= 10. *Indicates statistically significant (p < 0.05) difference from any other group. b Representative protein bands for
two isoforms (96 KDa and 67 KDa) of Dab2 in cultured astrocytes treated with sham (Control), siRNA negative control (−) or positive duplex chains (+).
Protein values are shown as the ratio of 96 kDa isoform and β-actin (42 kDa), and the ratio of 67 kDa isoform and β-actin. Data represent mean ± SD, n= 6.
*Indicates statistically significant (p < 0.05) difference from any other group. c Fe3+-dependent changes in the InsP3 after treatment with Dab2 siRNA
duplex chains. After treatment with Dab2 siRNA duplex chains (+) for 3 days, the primary cultured astrocytes were treated with serum-free medium
(Control), TF (as negative control) or 10 μM Fe3+-TF (Fe3+) for 5 minutes, the level of InsP3 was measured by ELISA and shown as mean ± SD, n= 10.
d Fe3+ -induced [Ca2+]i responses are Dab2 and PLC dependent. Treatment with Dab2 siRNA duplex chains (+) as well as with 10 μM U-73122 (PLC
inhibitor) suppressed Fe3+-induced [Ca2+]i responses. Every data point represents mean ± SD, n= 10. e Mechanisms of Fe3+-induced Ca2+ signalling in
astrocytes. The uptake of Fe3+ is mediated TFR, TFR internalization requires Dab2; when in the cytosol Fe3+ activated PLC thus stimulating InsP3-induced
Ca2+ release from the ER.
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changes originate from plasmalemmal Ca2+ entry, because
removal of Ca2+ from the extracellular medium inhibits [Ca2+]i
response. Finally, Fe2+-induced [Ca2+]i signals require NCX, as
pharmacological inhibition of the latter effectively suppresses
[Ca2+]i elevation (Fig. 3). These data indicate that Fe2+, after
being accumulated in the astrocyte, switches the NCX into the
reverse mode of operation thus generating Ca2+ influx into the
cell in exchange for Na+. This scenario requires increase in
astroglial [Na+]i, which readily reverses the NCX28,52. An
increase in [Na+]i is likely to result from the inhibition of NKA,
which represents the major Na+ efflux mechanism in
astrocytes30. Activity of NKA was effectively suppressed by Fe2+,
and probing astrocytes with Na+-sensitive indicator SBFI
revealed Fe2+-induced [Na+]i elevation (Fig. 4). In the presence
of NKA inhibitor ouabain Fe2+-induced [Ca2+]i responses were
eliminated thus corroborating the central role of NKA and NCX
in Fe2+-induced Ca2+ signalling (Figs. 4, 7). Of note, exposure to
Fe2+ initiated rapid redistribution of DMT1 from nucleus into
cytoplasm (Fig. 2g) and arguably to the plasmalemma thus
increasing astrocyte capacity for iron uptake.
The mechanism of Fe3+-induced Ca2+ signalling is associated
with intracellular Ca2+ release. The Fe3+-induced [Ca2+]i
responses are preserved in Ca2+-free extracellular solution while
being blocked by XeC (inhibitor of InsP3 receptor) and by U-
73122 (inhibitor of PLC) thus revealing the central role for InsP3-
medaited ER Ca2+ release. Initiation of this signalling cascade
requires transmembrane transport of Fe3+: in vitro knockdown of
TFR eliminates Fe3+-evoked [Ca2+]i dynamics. The internalisa-
tion of TF-Fe3+-TFR complex also requires functional Dab2
protein. This protein is a multi-modular scaffold protein with
signalling roles in ion homoeostasis, inflammation and receptors
internalization53. Ablation of Dab2 in astrocytes with specific
siRNA interrupts signalling chain and blocks Fe3+-dependent
Ca2+ signalling (Figs. 6 and 7).
Import of TF-Fe3+-TFR complex involves endocytosis; acidic
(pH ~5.6) environment of the endosome achieved through the
action of ATP-dependent H+ pumps54, reduces the affinity of TF
to Fe3+ and the latter is released55. Subsequently, an endosomal
reductase reduces Fe3+ to Fe2+, and Fe2+ can be transported into
the cytosol by DMT1 or by ZIP8 or ZIP14 Zn transporters56. Our
data question the DMT1 pathway because siRNA knockout of
DMT1 did not affect Fe3+-induced Ca2+ signalling; the detailed
mechanism of Fe3+ transport in astrocytes remains to be fully
characterised.
Caveolae are specific plasmalemmal structures that form
functional microdomains involved in various signalling, endocy-
totic and transporting events57. Caveolae and their main struc-
tural and regulatory proteins Caveolin-1,2,3 are present in
astrocytes (with predominant expression of Cav3); astrocytic
caveolae contribute to signal transduction, formation of signalling
protein complexes and are involved in action of various neu-
roactive substances and drugs58,59. Caveolae are known to form
functional Ca2+ signalling units, establish links between Ca2+
channels and various transports and may contribute to formation
of plasmalemmal/ER functional domains operational in
astrocytes60. We found that down-regulation of expression of
Cav3 in cultured astrocytes substantially reduced the amplitude of
Fe2+-evoked [Ca2+]i responses. We suggest therefore that Cav3
and caveolae integrate DMT1, NKA and NCX into a single Ca2+
signalling unit (Fig. 7); moreover exposure to iron potentiates
formation of such units.
Iron homoeostasis is of fundamental importance for cells, tis-
sues and organisms, as iron contributes to a wide range of vital
biological pathways61. The brain contains high concentrations of
bound and free iron, which participates in multiple processes from
energy production to synaptic transmission41. Iron overload and
failures in iron homoeostatic triggers neurotoxicity and is impli-
cated in brain diseases48. Genetic mutations of iron regulatory
proteins (the key elements of iron homoeostasis) result in iron
deposition in the brain with subsequent neurodegeneration
characteristic for aceruloplasminemia62 and neuroferritino-
pathy63. In aceruloplasminemia patients, iron overload has been
observed in astrocytes, particularly in the basal ganglia64. Cer-
uloplasmin oxidises Fe2+ to Fe3+ in order to generate the oxidised
form of iron that can bind to extracellular transferrin; in astrocytes
ceruloplasmin is also required for iron export64. Thus, in acer-
uloplasminemia, iron entering the CNS as ferrous might escape
oxidation; hence cells exposed to the excess of Fe2+ may readily
become iron overloaded65. Similarly, abnormal iron accumulation
has been characterised in neurodegenerative diseases including
Fig. 7 Mechanisms of Fe2+ and Fe3+ -induced intracellular Ca2+ signalling. Uptake of Fe2+ is mediated by DMT1 and uptake of Fe3+ is mediated by TFR.
After entering the cytosol, Fe2+ inhibits the activity of NKA, which causes an increase in [Na+]i due to an unopposed influx of Na+ through Na+-dependent
transporters or Na+-channels. Increase in [Na+]i switches the NCX into the reverse mode, which results in Ca2+ influx. This influx also activates Ca2+-
induced Ca2+ release through RyR that contributes to the plateau phase of [Ca2+]i response. Accumulation of Fe2+ also promotes the formation of the
functional unit of DMT1, NCX1 and NKA in the caveolae by recruiting Cav3. Uptake of Fe3+ proceeds through Dab2-assisted internalisation; after entering
the cytosol, Fe3+ activates the PLC and stimulates InsP3-dependent Ca2+ release from the ER.
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Alzheimer’s disease, Parkinson disease, amyotrophic lateral
sclerosis and Huntington disease to name but a few48. Specific
class of neurodegeneration with brain iron accumulation (NBIA)
has been also categorised in recent years66.
Based on our data we propose that astrocytes mount the
defence against acute iron overload. This defence includes iron
accumulation through both DMT1 and TFR, redistribution of
DMT1 from intracellular locations to plasmalemma and gen-
eration of Ca2+ signals, which control astrocytic reactivity. Iron-
induced Ca2+ signalling is activated at low pathological iron
concentrations (>1 μM; while physiological iron concentration in
the CSF ranges between 0.3 and 0.75 μM). Importantly, two
distinct signalling cascades (DMT1 Fe2+ transport, inhibition of
NKA and reversal of NCX versus Fe3+-TF-TFR transport, acti-
vation of PLC and generation of InsP3-induced Ca2+ release)
distinguish between ferric and ferrous. These distinct pathways
may define very different outputs: it is known for example that
activation of astroglial InsP3 receptors type II is linked to initia-
tion of reactive astrogliosis67,68. In our recent report, exposure to
iron was found to stimulate the over-expression of DMT1 in
astrocytes and microglia, but not in neurones, which may result
in the neuroprotection by glial uptake of excessive iron13.
Astrogliosis plays important, if not defining role in evolution of
many neurological diseases69. Our previous experiments have
shown that formation of brain deposits of iron up-regulates
astroglial expression of TFR and instigates reactive astrogliosis70.
What characterises the iron-induced reactive phenotype and what
is the role of astroglial reactivity in managing excessive iron in the
brain remains to be found. In conclusion, our study presented a
phenomenon that iron ions (Fe2+ and Fe3+) directly induce
intracellular Ca2+ signalling and stimulate astroglial protective
mechanisms against iron overload in broad pathological contexts.
Methods
Materials. The culture medium including DMEM and fetal bovine serum were
purchased from Gibco Life Technology Invitrogen (Grand Island, NY, USA).
Oligo-fectamine, MEMI, fluo-4 AM, sodium-binding benzofuran isophthalate
(SBFI) AM, G-agarose bead, TFR antibody, β-actin antibody, GFAP antibody,
DMT1 antibody and DMT1 siRNA duplex chains were from Thermo Fisher Sci-
entific (Waltham, MA USA); siRNA duplex chains of TFR, NCX1-3, Cav-3 and
Dab2, NCX2 antibody, Na+/K+-ATPase alpha1/2 antibody and the secondary
antibodies were bought from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
NCX1 antibody, NCX3 antibody and native mouse apo-transferrin (apo-TF; i.e.,
iron-free) were from Abcam (Cambridge, MA, USA). Donkey serum, xestospongin
C (Xe-C), nifedipine, ferrous sulfate heptahydrate (FeSO4), sulforhodamine 101
(SR101) and ferric ammonium citrate were purchase from Sigma-Aldrich (St.
Louis, MO, USA). Ryanodine and KB-R7943 were purchased from Calbiochem (La
Jolla, CA, USA). Secondary antibody staining with donkey anti-mouse or anti-
rabbit Cy-2/3 were from Jackson Immuno-Research (West Grove, PA, USA).
Primary antibody of histone H3 was purchased from EarthOx (Millbrae,
CA, USA).
Animals. The C57BL/6 mice, FVB/N-Tg(GFAP-eGFP)14Mes/J and B6.Cg-Tg
(Thy1-YFP)HJrs/J transgenic mice were all purchased from the Jackson Laboratory
(Bar Harbor, ME, USA). The animals were raised in standard housing conditions
(22 ± 1 °C; light/dark cycle of 12/12 h), with water and food available ad libitum.
All experiments were performed in accordance with the US National Institutes of
Health Guide for the Care and Use of Laboratory Animals (NIH Publication No.
8023) and its 1978 revision, and all experimental protocols were approved by the
Institutional Animal Care and Use Committee of China Medical University, No.
[2019]059.
Primary culture of astrocytes. Astrocytes were cultured from newborn mice71,72.
In brief, the cerebral hemispheres were isolated, dissociated and filtered. Isolated
astrocytes were grown in Dulbecco’s Minimum Essential Medium (DMEM) with
7.5 mM glucose supplemented with 10% foetal bovine serum. Astrocytes were
incubated at 37 °C in a humidified atmosphere of CO2/air (5:95%). The cultures are
highly enriched in astrocytes, the purity is >95% as judged by GFAP staining73.
Iron treatment. For preparing Fe3+-TF solution, ferric ammonium citrate and
mouse apo-TF were incubated at a 2:1 ratio in serum-free culture medium for 1 h
at 37 °C74,75. The same concentration of apo-TF in the same volume of culture
medium but without Fe3+ was used for control treatments. For the Fe2+ solution,
FeSO4 was freshly dissociated in serum-free culture medium at 37 °C and used
immediately, the same volume of serum-free culture medium was used as the
control for Fe2+ group.
RNA interfering. The cultured astrocytes were incubated in DMEM without serum
for 12 hours before transfection73,76,77. A transfection solution containing 2 μl
oligo-fectamine (Promega, Madison, WI, USA), 40 μl MEMI, and 2.5 μl siRNA
(DMT1, TFR, NCX1-3, Cav-3 or Dab2) was added to the culture medium in every
well for 8 h. In the siRNA-negative control cultures, transfection solution without
siRNA was added. Thereafter, DMEM with three times serum was added to the
cultures. These siRNA duplex chains were purchased from Santa Cruz Bio-
technology (CA, USA).
Preparation of membrane caveolae. Cell homogenization and the caveolae pre-
paration from astrocytes was made78,79. In brief, primary cultured astrocytes were
collected and homogenised in SET (0.315M sucrose, 20 mM Tris-HCl, and 1 mM
EDTA, pH 7.4), and centrifuged for 1 h at 1,000 × g. The pellets were re-solubilised
in SET and layered on Percoll (30% in SET) followed centrifugation at 1,000 × g.
The pellets were re-homogenised and re-layered to three sucrose density gradient
solution (80%, 30% and 5%) with ultra-centrifugation at 175,000 × g. Finally, the
purified caveolae were collected and re-suspended in SET.
Co-immunoprecipitation. We used technologies of co-immunoprecipitation and
subsequent western blotting to check the conjunction level between NCXs and
DMT176. After homogenization, protein content was determined by the Bradford
method80 using bovine serum albumin as the standard. For immunoprecipitation
of NCX1-3, whole cell lysates (500 μg) were incubated with 20 μg of anti-NCX1,
anti-NCX2 or anti-NCX3 antibody for overnight at 4 °C. Then, 200 μl of washed
protein G-agarose bead slurry was added, and the mixture was incubated for
another 2 hours at 4 °C. The agarose beads were washed three times with cold
phosphate buffer solution (PBS) and collected by pulsed centrifugation (5 s in a
microcentrifuge at 14,000 × g), the supernatant was drained off, and the beads were
boiled for 5 min. Thereafter, the supernatant was collected by pulsed centrifuga-
tion, and the entire immunoprecipitates were subjected to 10% sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE).
Cytoplasm and nucleus protein extraction. The subcellular fraction was analyzed
using the protein extraction Kit (P0028, Beyotime, Shanghai, China)81, according
to the manufacturer’s protocol. For further western blotting assays, cytoplasmic
and nucleic protein extractions were kept under −20 °C.
Western blotting. For quantifying expressions of DMT1, TFR, NCX1-3, Cav-3 or
Dab2, the samples containing 100 μg of protein were added to slab gels. After
transferring to PVDF membranes, the samples were blocked by 10% skimmed milk
powder for 1 h, and membranes were incubated overnight with the primary
antibodies, specific to either DMT1 at a 1:300 dilution, TFR at a 1:200 dilution,
NCX1 at a 1:100 dilution, NCX2 at a 1:200 dilution, NCX3 at a 1:150 dilution, Cav-
3 at a 1:200 dilution, Dab2 at a 1:100 dilution, Histone H3 at 1:500 dilution or β-
actin at a 1:1000 dilution. After washing, specific binding was detected by horse-
radish peroxidase-conjugated secondary antibodies. Images were analysed with an
Electrophoresis Gel Imaging Analysis System (MF-ChemiBIS 3.2, DNR Bio-
Imaging Systems, Israel). Band density was measured with Window AlphaEaseTM
FC 32-bit software72,82.
Monitoring of [Ca2+]i. For [Ca2+]i monitoring and imaging in cultured
astrocytes83,84, after the pre-treatment with or without inhibitors or siRNA duplex
chains, the primarily cultured astrocytes were loaded with 5 μM fluo-4-AM,
(Thermo Fisher Scientific (Waltham, MA USA)), for 30 min. Fluo-4 signals were
visualised by fluorescent microscopy (Olympus IX71, Japan). The readings from all
fluo-4 positive cells in one measured field of view in each culture were included in
the statistics, the fluorescence intensity of fluo-4 was normalised to the baseline
intensity before stimulation. The measurements were repeated in 10 different
cultures. Cultured astrocytes were also stained with specific marker sulforhodamine
101 (SR101) at 1:2000 dilution.
Two-photon in vivo Ca2+ imaging. Adult FVB/N-Tg(GFAP-eGFP)14Mes/J
transgenic mice (10–12 weeks old) were anesthetized with ketamine (80 mg/kg, i.p.)
and xylazine (10 mg/kg, i.p.). Body temperature was monitored using a rectal
probe, and the mice were maintained at 37 °C by a heating blanket. A custom made
metal plate was glued to the skull with dental acrylic cement and a cranial window
was prepared over the right hemisphere at 2.5 mm lateral and 2 mm posterior to
bregma. The somato-sensory cortical cells were loaded with Ca2+ indicator Rhod-2
AM (50 μM, 1 h). The transcranial window was superfused with artificial CSF.
After a stable baseline recording was obtained, Fe2+ (100 μM) or Fe3+-TF
(100 μM) was added for 1 min. Bandpass filters (Chroma) were 540 nm/40 nm
for eGFP and 850 nm/70 nm for rhod-2 signals. Time-lapse images of astrocytic
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Ca2+ signalling were recorded every 5 s using FluoView with a custom-built two-
photon laser-scanning setup (Nikon AR1, Japan)84,85.
Intracellular Na+ measurements. For monitoring intracellular ionised Na+
([Na+]i) in cultured astrocytes, primary cultured astrocytes were loaded with
10 μM of Na+-sensitive indicator SBFI-AM for 30 min in serum-free medium, with
subsequent 1 h of washout. SBFI was alternatively excited at 340 nm and 380 nm,
and the emission was monitored at 500 nm. The SBFI signals were measured
by fluorescent microscopy (Olympus IX71, Japan) and expressed as a ratio (R=
F340/F380)52.
Immunofluorescence. The brain tissue was fixed by immersion in 4% paraf-
ormaldehyde and cut into 100 μm slices72,82. The cultured cells were fixed with
100% methanol at −20 °C. Brain slices or cells were permeabilised by incubation
for 1 h with donkey serum. Primary antibodies against DMT1 or TFR were used at
a 1:100 dilution, against glial fibrillary acidic protein (GFAP) was used at 1:200
dilution. And nuclei were stained with marker 4′, 6′-diamidino-2-phenylindole
(DAPI) at 1:1000 dilution. The primary antibodies were incubated overnight at
4 °C and then donkey anti-mouse or anti-rabbit Cy-2/3 conjugated secondary
antibody for 2 h at room temperature. Images were captured using a confocal
scanning microscope (DMi8, Leica, Wetzlar, Germany).
ELISA assays. Astrocytes were incubated at 37 °C in a fresh serum-free culture
medium; after the treatment with Fe2+/Fe3+ or inhibitors, the astrocytes were
collected and centrifuged at 10,000 × g for 10 min to remove floating cells and/or
cell debris at 4 °C. To assay the NKA activity, a commercial ELISA kit (abx255202;
Abbexa, Cambridge, UK) was used and operated as the protocols, the sensitivity is
0.19 ng/mL, the optical density (OD) was measured at 450 nm and the OD value
was normalized by the control group. To assay the InsP3 concentration86, the
supernatant was collected and the concentration of InsP3 assayed using a com-
mercial ELISA kit (E-EL-0059c; Elabscience Biotechnology, Wuhan, China).
Sorting neural cells through fluorescence activated cell sorter (FACS) and
quantitative PCR (qPCR). To measure the mRNA for TFR and DMT1, astrocytes
expressing fluorescent marker GFP (GFAP-GFP mice) and neurons expressing
fluorescent marker YFP (Thy1-YFP mice) were used; we also extracted the cerebral
hemispheres tissues from wild type mice. The cells from transgenic mice were used
for specific sorting of astrocytes or neurons with FACS85,87. The RNA of the sorted
cells and cerebral tissue was extracted by Trizol. Total RNA was reverse transcribed
and PCR amplification was performed in a Robo-cycler thermocycler81,84. The
relative quantity of transcripts was assessed using five-folds serial dilutions of RT
product (200 ng). RNA quantity was normalised to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and values are expressed as the ratio TFR/GAPDH or
DMT1/GAPDH.
Statistics and reproducibility. For statistical analysis, we used one-way analysis of
variance (ANOVA) followed by a Tukey’s or Dunnett’s post hoc multiple com-
parison test for unequal replications using GraphPad Prism 5 software (GraphPad
Software Inc., La Jolla, CA) and SPSS 24 software (International Business Machines
Corp., NY, USA). One-way ANOVA for comparisons including more than two
groups; unpaired two-tailed t-test for two-group comparisons. All statistical data in
the text are presented as the mean ± SD, the value of significance was set at p < 0.05.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data underlying the main and supplementary figures are available in
Supplementary Data. The data that support the findings of this study are available from
the corresponding author Baoman Li upon reasonable request.
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